Killer immunoglobulin-like receptors

Current Opinion in Immunology

Volumn 16, Issue 5, 2004, Pages 626-633

  Moretta, Lorenzo ^a,b   Moretta, Alessandro ^b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; DNA; HLA ANTIGEN; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ALLOGENIC BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CELL FUNCTION; CELL KILLING; COMPARATIVE STUDY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC ORGANIZATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; IMMUNITY; INHIBITION KINETICS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PHYLOGENY; PRIMATE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; SURFACE PROPERTY; T LYMPHOCYTE SUBPOPULATION; TUMOR;

ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; PHYLOGENY; RECEPTORS, IMMUNOLOGIC;

EID: 4444243490     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2004.07.010     Document Type: Review

References (67)

1. G. Trinchieri Biology of natural killer cells Adv Immunol 47 1989 187 376
2. L. Moretta, E. Ciccone, M.C. Mingari, R. Biassoni, and A. Moretta Human NK cells: origin, clonality, specificity and receptors Adv Immunol 55 1994 341 380
3. C.A. Janeway Jr., and R. Medzhitov Innate immune recognition Annu Rev Immunol 20 2002 197 216
4. A. Moretta Natural killer cells and dendritic cells: rendezvous in abused tissues Nat Rev Immunol 2 2002 957 965
5. P. Parham The unsung heroes Nature 423 2003 20 A minireview outlining innate immunity, including NK cells, which play a major role in the early phases of immune responses and may eradicate infections before these cause manifest disease. For this reason the role of innate immunity has often been underestimated.
6. A. Moretta, C. Bottino, M. Vitale, D. Pende, R. Biassoni, M.C. Mingari, and L. Moretta Receptors for HLA-class I molecules in human Natural Killer cells Annu Rev Immunol 14 1996 619 648
7. A. Moretta, C. Bottino, M.C. Mingari, R. Biassoni, and L. Moretta What is a Natural Killer cell? Nat Immunol 3 2002 6 8
8. L.L. Lanier NK cell receptors Annu Rev Immunol 16 1998 359 393
9. E.O. Long Regulation of immune responses through inhibitory receptors Annu Rev Immunol 17 1999 875 904
10. M. Lopez-Botet, M. Llano, F. Navarro, and T. Bellon NK cell recognition of non-classical HLA class I molecules Semin Immunol 12 2000 109 119
11. A. Moretta, C. Bottino, M. Vitale, D. Pende, C. Cantoni, M.C. Mingari, R. Biassoni, and L. Moretta Activating receptors and co-receptors involved in human natural killer cell-mediated cytolysis Annu Rev Immunol 19 2001 197 223
12. A. Moretta, R. Biassoni, C. Bottino, M.C. Mingari, and L. Moretta Natural cytotoxicity receptors that trigger human NK-mediated cytolysis Immunol Today 21 2000 228 234
13. S. Sivori, M. Vitale, L. Morelli, L. Sanseverino, R. Augugliaro, C. Bottino, L. Moretta, and A. Moretta p46, a novel Natural Killer cell-specific surface molecule which mediates cell activation J Exp Med 186 1997 1129 1136
14. A. Pessino, S. Sivori, C. Bottino, A. Malaspina, L. Morelli, L. Moretta, R. Biassoni, and A. Moretta Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity J Exp Med 188 1998 953 960
15. D. Pende, S. Parolini, A. Pessino, S. Sivori, R. Augugliaro, L. Morelli, E. Marcenaro, L. Accame, A. Malaspina, and R. Biassoni Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells J Exp Med 190 1999 1505 1516
16. M. Vitale, C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, R. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta NKp44, a novel triggering surface molecule specifically expressed by activated Natural Killer cells is involved in non-MHC restricted tumor cell lysis J Exp Med 187 1998 2065 2072
17. C. Cantoni, C. Bottino, M. Vitale, A. Pessino, R. Augugliaro, A. Malaspina, S. Parolini, L. Moretta, A. Moretta, and R. Biassoni NKp44, a triggering receptor involved in tumor cell lysis by activated human Natural Killer cells, is a novel member of the immunoglobulin superfamily J Exp Med 189 1999 787 796
18. D.H. Raulet Roles of the NKG2D immunoreceptor and its ligands Nat Rev Immunol 3 2003 781 790
19. J.P. Houchins, T. Yabe, C. McSherry, and F.H. Bach DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells J Exp Med 173 1991 1017 1020
20. A. Cerwenka, and L.L. Lanier Ligands for natural killer cell receptors: redundancy or specificity Immunol Rev 181 2001 158 169
21. S. Sivori, S. Parolini, M. Falco, E. Marcenaro, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta 2B4 functions as a co-receptor in human natural killer cell activation Eur J Immunol 30 2000 787 793
22. C. Bottino, M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L. Notarangelo, and L. Moretta NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill epstein-barr virus-infected B cells in X-linked lymphoproliferative diseases J Exp Med 194 2001 235 246
23. M. Vitale, M. Falco, R. Castriconi, S. Parolini, R. Zambello, G. Semenzato, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta Identification of NKp80, a novel triggering molecule expressed by human natural killer cells Eur J Immunol 31 2001 233 242
24. E. Marcenaro, R. Augugliaro, M. Falco, R. Castriconi, S. Parolini, S. Sivori, E. Romeo, R. Millo, L. Moretta, and C. Bottino CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotocicity Eur J Immunol 33 2003 3367 3376
25. A. Shibuya, D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, T. McClanahan, T. Kitamura, J. Nicholl, G.R. Sutherland, and L.L. Lanier DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes Immunity 4 1996 573 581
26. C. Bottino, R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, and N. Reymond Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule J Exp Med 198 2003 557 567 A relevant study demonstrating that DNAM-1 may function as an activating receptor in NK cells. The identification of PVR and nectin-2 as DNAM-1 ligands and the demonstration that their expression is highly upregulated in tumours provides new insight in the molecular interactions between NK and tumour cells.
27. N. Reymond, A.-M. Imbert, E. Devilard, S. Fabre, C. Chabannon, L. Xerri, C. Farnarier, C. Cantoni, C. Bottino, and A. Moretta DNAM-1 and PVR regulate monocyte migration through endothelial junctions J Exp Med 199 2004 1331 1341
28. M. Bennet Biology and genetics of hybrid resistance Adv Immunol 41 1987 333 445
29. A. Moretta, G. Tambussi, C. Bottino, G. Tripodi, A. Merli, E. Ciccone, G. Pantaleo, and L. Moretta A novel surface antigen expressed by a subset of human CD3-CD16+ Natural Killer cells. Role in cell activation and regulation of cytolytic function J Exp Med 171 1990 695 714
30. A. Moretta, C. Bottino, D. Pende, G. Tripodi, G. Tambussi, O. Viale, A.M. Orengo, M. Barbaresi, A. Merli, and E. Ciccone Identification of four subset of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition J Exp Med 172 1990 1589 1598
31. A. Moretta, M. Vitale, C. Bottino, A.M. Orengo, L. Morelli, R. Augugliaro, M. Barbaresi, E. Ciccone, and L. Moretta p58 molecules as putative receptors for MHC class I molecules in human Natural Killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities J Exp Med 178 1993 597 604
32. N. Wagtmann, R. Biassoni, C. Cantoni, S. Verdiani, M.S. Malnati, M. Vitale, C. Bottino, L. Moretta, A. Moretta, and E.O. Long Molecular clones of the p58 Natural Killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains Immunity 2 1995 439 449
33. M. Colonna, and J. Samaridis Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells Science 268 1995 405 408
34. M.G. Brown, A.A. Scalzo, K. Matsumoto, and W.M. Yokoyama The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity Immunol Rev 155 1997 53 65
35. H.R. Smith, A.H. Idris, and W.M. Yokoyama Murine natural killer cell activation receptors Immunol Rev 181 2001 115 125
36. D.H. Raulet, R.E. Vance, and C.W. McMahon Regulation of the natural killer cell receptor repertoire Annu Rev Immunol 19 2001 291 330
37. V. Litwin, J. Gumperz, P. Parham, J.H. Phillips, and L.L. Lanier NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules J Exp Med 180 1994 537 544
38. M. Vitale, S. Sivori, D. Pende, R. Augugliaro, C. Di Donato, A. Amoroso, M. Malnati, C. Bottino, L. Moretta, and A. Moretta Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones Proc Natl Acad Sci USA 93 1996 1453 1457
39. D. Pende, R. Biassoni, C. Cantoni, S. Verdiani, M. Falco, C. Di Donato, L. Accame, C. Bottino, A. Moretta, and L. Moretta The Natural Killer cell receptor specific for HLA.A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kD disulphide-linked dimer J Exp Med 184 1996 505 518
40. C. Dohring, and M. Colonna Human natural killer cell inhibitory receptors bind to HLA class I molecules Eur J Immunol 26 1996 365 369
41. A. Moretta, S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, C. Bottino, and L. Moretta Existence of both inhibitory (p58) and activatory (p50) receptors for HLA.C molecules in human Natural Killer cells J Exp Med 182 1995 875 884
42. R. Biassoni, C. Cantoni, M. Falco, S. Verdiani, C. Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta The HLA.C specific "activatory" and "inhibitory" Natural Killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions J Exp Med 183 1996 645 650
43. C. Bottino, S. Sivori, M. Vitale, C. Cantoni, M. Falco, D. Pende, L. Morelli, R. Augugliaro, G. Semenzato, and R. Biassoni A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human Natural Killer cells and induces both triggering of cell functions and proliferation Eur J Immunol 26 1996 1816 1824
44. M.C. Mingari, C. Vitale, A. Cambiaggi, F. Schiavetti, G. Melioli, S. Ferrini, and A. Poggi Cytolytic T lymphocytes displaying natural killer (NK)-like activity. Expression of NK-related functional receptors fir HLA-class I molecules (p58 and CD94) and inhibitory effect ib tge TCR-mediated target cell lysis or lymphokine production Int Immunol 7 1995 697 703
45. L. Moretta, C. Romagnani, G. Pietra, A. Moretta, and M.C. Mingari NK-CTL, a novel HLA-E-restricted T cell subset Trends Immunol 24 2003 136 143 A review illustrating the KIR+ (or CD94/NKG2A+) CD8+ cytolytic T-cell subset specific for HLA-E. The role of its unique TCR specificity and of KIR expression in determining their broad alloreactivity and the implication in transplantation are analysed.
46. E. Vivier, and N. Anfossi Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future Nat Rev Immunol 4 2004 190 198
47. L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, S. Tosti, S. Posati, D. Rogaia, F. Frassoni, and F. Aversa Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097 2100
48. A. Velardi, L. Ruggeri, A. Moretta, and L. Moretta NK cells: a lesson from mismatched hematopoietic transplantation Trends Immunol 23 2002 438 444
49. S. Sivori, C. Cantoni, S. Parolini, E. Marcenaro, L. Moretta, and A. Moretta IL21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors Eur J Immunol 33 2003 3439 3447
50. H.G. Shilling, N. Young, L.A. Guethlein, N.W. Cheng, C.M. Gardiner, D. Tyan, and P. Parham Genetic control of human NK cell repertoire J Immunol 169 2002 239 247
51. H.G. Shilling, K.L. McQueen, N.W. Cheng, J.A. Shizuru, R.S. Negrin, and P. Parham Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation Blood 101 2003 3730 3740 This study provides further evidence to [50] that the KIR repertoires of NK cells developing from stem cells in bone marrow transplantation are of donor type.
52. C. Vilches, and P. Parham KIR: diverse, rapidly evolving receptors of innate and adaptive immunity Annu Rev Immunol 20 2002 217 251
53. R. Biassoni, A. Pessino, C. Bottino, D. Pende, L. Moretta, and A. Moretta The murine homologoue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity Eur J Immunol 29 1999 1014 1020
54. H. Kubawa, M.D. Cooper, C.C. Chen, L.H. Ho, T.L. Alley, V. Hurez, T. Tun, T. Uehara, T. Shimada, and P.D. Burrows Paired immunoglobulin-like receptors of activating and inhibitory types Curr Top Microbiol Immunol 244 1999 137 149
55. M.P. Martin, A. Bashirova, J. Traherne, J. Trowsdale, and M. Carrington Cutting edge: expansion of the KIR locus by unequal crossing over J Immunol 171 2003 2192 2195 This study provides evidence for a molecular mechanism involved in the expansion of the KIR locus and leading to the rapid diversification of KIR haplotypes.
56. M. Uhrberg, N.M. Valiante, B.P. Shum, H.G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L.L. Lanier, and P. Parham Human diversity in killer cell inhibitory receptor genes Immunity 7 1997 753 763
57. H.G. Shilling, A.G. Lisbeth, N.W. Cheng, C.M. Gardiner, R. Rodriguez, D. Tyan, and P. Parham Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype J Immunol 168 2002 2307 2315
58. K.C. Hsu, X.-R. Liu, A. Selvakumar, E. Mickelson, R.J. O'Reilly, and B. Dupont Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets J Immunol 169 2002 5118 5129
59. M. Uhrberg, P. Parham, and P. Wernet Definition of gene content for nine common group B haplotypes of the caucasoid population: KIR haplotypes contain between seven and eleven KIR genes Immunogenetics 54 2002 221 229
60. R. Zambello, M. Della Chiesa, L. Trentin, D. Carollo, R. Castriconi, G. Cannas, S. Carlomagno, M. Falco, A. Cabrelle, and T. Lamy Expression and functional and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) Blood 102 2003 1797 1805
61. K. Artavanis-Tsakonas, K. Eleme, K.L. McQueen, N.W. Cheng, P. Parham, D.M. Davis, and E.M. Riley Activation of a subset of human NK cells upon contact with plasmodium falciparum-infected erythrocytes J Immunol 171 2003 5396 5405 An interesting study illustrating how some NK cells can be activated upon interaction with plasmodium infected erythrocytes. The authors provide also evidence that the human population of African or Asian origin analysed in their study displayed relevant differences in the KIR repertoire.
62. S. Santaourlidis, H.-I. Trompeter, S. Weinhold, B. Eisermann, K.L. Meyer, P. Wernet, and M. Uhrberg Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells J Immunol 169 2002 4253 4261
63. H.-W. Chan, Z.B. Kurago, C.A. Stewart, M.J. Wilson, M.P. Martin, B.E. Mace, M. Carrington, J. Trowsdale, and C.T. Lutz DNA methylation maintains allele-specific KIR gene expression in human natural killer cells J Exp Med 197 2003 245 255 In agreement with [62] these authors define the role of DNA methylation in the control of KIR expression. They show also that this mechanism is responsible for maintaining the monoallelic expression of KIR.
64. M.J. Pando, C.M. Gardiner, M. Gleimer, K.L. McQueen, and P. Parham The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1 J Immunol 171 2003 6640 6649 Variability in KIR allele surface expression may be greatly influenced by a critical mutation in the D0 domain. This largely prevents the expression of a common allele of KIR3DL1.
65. S.I. Khakoo, R. Geller, S. Shin, J.A. Jenkins, and P. Parham The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer J Exp Med 196 2002 911 921
66. L.A. Guethlein, L.R. Flodin, E.J. Adams, and P. Parham NK cell receptors of the orangutan (Pongo pygmaeus): a pivotal species for tracking the coevolution of killer cell Ig-like receptors with MHC-C J Immunol 169 2002 220 229
67. R. Rajalingam, P. Parham, and L. Abi-Rached Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors J Immunol 172 2004 356 369 A comparative analysis of different species in this study identifies the main mechanism responsible for the formation of new KIRs in primates.